Total Payments
$19,688
2024 Payments
$1,761
Companies
47
Transactions
592
Medicare Patients
14,145
Medicare Billing
$987,603
Payment Breakdown by Category
Food & Beverage$12,205 (62.0%)
Travel$7,291 (37.0%)
Other$155.04 (0.8%)
Education$37.22 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,205 | 570 | 62.0% |
| Travel and Lodging | $7,291 | 15 | 37.0% |
| Entertainment | $155.04 | 2 | 0.8% |
| Education | $37.22 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $7,949 | 72 | $0 (2020) |
| Medtronic, Inc. | $1,892 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,497 | 102 | $0 (2024) |
| Philips Electronics North America Corporation | $836.62 | 5 | $0 (2023) |
| Amgen Inc. | $827.74 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $803.48 | 69 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $731.02 | 38 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $492.57 | 32 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $465.93 | 28 | $0 (2024) |
| Boston Scientific Corporation | $419.64 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,761 | 62 | Philips North America LLC ($390.24) |
| 2023 | $1,112 | 53 | Novartis Pharmaceuticals Corporation ($195.81) |
| 2022 | $1,955 | 59 | Medtronic, Inc. ($1,158) |
| 2021 | $1,285 | 69 | Novartis Pharmaceuticals Corporation ($442.61) |
| 2020 | $2,892 | 68 | Medtronic Vascular, Inc. ($2,147) |
| 2019 | $1,274 | 80 | Janssen Pharmaceuticals, Inc ($253.71) |
| 2018 | $7,896 | 121 | Medtronic Vascular, Inc. ($5,468) |
| 2017 | $1,514 | 80 | Abbott Laboratories ($198.52) |
All Payment Transactions
592 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Renal Denervation System | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Stents | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Stents | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.35 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Philips North America LLC | (BQ9) Coronary IVUS (Device) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Medical Device | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2024 | Philips North America LLC | (BQ9) Coronary IVUS (Device) | Food and Beverage | Cash or cash equivalent | $44.03 | General |
| Category: Medical Device | ||||||
| 10/24/2024 | Philips North America LLC | (BQ9) Coronary IVUS (Device) | Food and Beverage | Cash or cash equivalent | $325.62 | General |
| Category: Medical Device | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.76 | General |
| Category: Cardiovascular | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: Lithoplasty | ||||||
| 09/20/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $102.95 | General |
| Category: AVVIGO_IC | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $24.85 | General |
| 09/14/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $164.75 | General |
| Category: Renal Denervation System | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Stents | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,017 | 3,742 | $2.3M | $221,959 |
| 2022 | 28 | 3,469 | 4,056 | $1.7M | $217,583 |
| 2021 | 28 | 3,629 | 4,478 | $2.0M | $267,114 |
| 2020 | 29 | 4,030 | 4,928 | $2.1M | $280,947 |
Total Patients
14,145
Total Services
17,204
Medicare Billing
$987,603
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 27 | 40 | $1.5M | $50,208 | 3.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 368 | 472 | $112,336 | $39,069 | 34.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 42 | 51 | $90,661 | $21,126 | 23.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 369 | 378 | $115,668 | $17,771 | 15.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 119 | 123 | $56,211 | $15,630 | 27.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 83 | 83 | $79,690 | $14,096 | 17.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 69 | 138 | $32,292 | $12,179 | 37.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 36 | 187 | $23,375 | $8,227 | 35.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 126 | 127 | $50,038 | $6,761 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $19,345 | $5,480 | 28.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 396 | 509 | $50,900 | $5,023 | 9.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 571 | 633 | $31,650 | $3,630 | 11.5% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $20,007 | $3,395 | 17.0% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 34 | 41 | $11,431 | $2,885 | 25.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 73 | $4,693 | $2,472 | 52.7% |
| 0715T | Shockwave destruction of calcified plaque in coronary artery accessed through skin using catheter | Facility | 2023 | 16 | 19 | $9,956 | $2,263 | 22.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 36 | 36 | $11,016 | $1,838 | 16.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 131 | 132 | $22,044 | $1,297 | 5.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 107 | 121 | $5,445 | $1,141 | 21.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 71 | 71 | $11,857 | $1,112 | 9.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 14 | 14 | $5,516 | $818.02 | 14.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 31 | 31 | $3,782 | $784.46 | 20.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 20 | 85 | $2,975 | $728.74 | 24.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 31 | 33 | $4,917 | $714.96 | 14.5% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 38 | 38 | $4,066 | $616.00 | 15.2% |
About Dr. Robert Smith, MD
Dr. Robert Smith, MD is a Cardiovascular Disease healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598750739.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Smith, MD has received a total of $19,688 in payments from pharmaceutical and medical device companies, with $1,761 received in 2024. These payments were reported across 592 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($12,205).
As a Medicare-enrolled provider, Smith has provided services to 14,145 Medicare beneficiaries, totaling 17,204 services with total Medicare billing of $987,603. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Tyler, TX
- Active Since 09/14/2005
- Last Updated 04/26/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1598750739
Products in Payments
- Endeavor (Device) $4,940
- Resolute (Device) $2,591
- ENTRESTO (Drug) $1,189
- XARELTO (Drug) $803.48
- SIMULUS (Device) $801.43
- IVUS Systems (Device) $787.31
- ELIQUIS (Drug) $568.84
- BRILINTA (Drug) $556.12
- Corlanor (Drug) $503.74
- JARDIANCE (Drug) $405.29
- (BQ9) Coronary IVUS (Device) $390.24
- Telescope (Device) $356.06
- Repatha (Biological) $324.00
- LEQVIO (Drug) $308.29
- MOSAIC (Device) $297.36
- LifeVest (Device) $245.07
- SYMPLICITY G3 (Device) $200.78
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $195.70
- MULTAQ (Drug) $183.26
- Vascepa (Drug) $168.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Tyler
Dr. John Sims, M.d, M.D
Cardiovascular Disease — Payments: $188,298
Cardiovascular Disease $188,298
Sherif Iskander, Md, MD
Cardiovascular Disease — Payments: $91,158
Cardiovascular Disease $91,158
Thaddeus Tolleson, Md, MD
Cardiovascular Disease — Payments: $53,717
Cardiovascular Disease $53,717
Dr. Jarett Berry, Md, MD
Cardiovascular Disease — Payments: $23,553
Cardiovascular Disease $23,553
Dr. Augustine Njoku, M.d, M.D
Cardiovascular Disease — Payments: $15,238
Cardiovascular Disease $15,238
Hector Ceccoli, Md, MD
Cardiovascular Disease — Payments: $15,193
Cardiovascular Disease $15,193